Until this week, I remained a NoVid, which I chalked up to being fairly cautious, fully vaxxed & a bit lucky.
This week my luck ran out. My case is a cautionary tale, particularly for the “just a cold” folks. Mine definitely was not...I literally have scars to show for it. (1/22)
Testing is still an important tool to keep people safe from #COVID19, write Nathaniel Hafer, PhD, and Apurv Soni, MD, PhD’21, of UMass Chan and Yukari Manabe, MD, of @JohnsHopkins. The testing experts answer common questions: https://t.co/ipoWxlqcwb @NateHafer@ConversationUS
New #COVID19 research from @UMassChanSOM@herbert_carly: ‘Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2’ https://t.co/ZCY6GnrthE
Aannndd you can check out our results at @AnnalsofIM! The results remain consistent: rapid antigen tests for COVID-19 work among people with Omicron infection. @COVID19TestUs@UMassChan_PDM@UMassChan https://t.co/TbP3kDWYMv
“Nobody else has COVID information at this level of detail.” - Doyle Ward, PhD
UMass Chan researchers have developed an app that gives epidemiologists and public health leaders access to Central Mass. COVID data: https://t.co/yrMiKaOjt9 @herbert_carly@BethAMcCormick@jmirpub
One of my favorite projects was published today! If we give people easier ways to report their rapid antigen test results to public health departments, will they do it? @UMassChan_PDM@UMass_Medicine@COVID19TestUs
In a free testing program, >75% of those sent #COVID19 tests who used the digital assistant reported their rapid antigen test results to their state public health department, more so with incentives. @herbert_carly@covid19testus#OAResearch https://t.co/VVAYVZo9vy
We're recruiting a cohort of six Ph.D. students to start Fall 2023 and participate in a new Institute training program focused on biological integration across scales, from molecular virology up to climate change. Please share widely! Details here: https://t.co/TPoGjhEIhc
If you are sick for 1-2 days and test negative for #Covid_19, remember that home tests may be negative the first few days.
Your individualized immunity level from prior infection, vaccination, or your hybrid immunity has a lot to do with that result.
Take another test in 48 hrs
The data that FDA largely considered is from this paper by Soni et al.
https://t.co/60kqhfcXB1
And FDA new guidance is
https://t.co/TGX183FBOk
I honestly don't have the energy to talk about the absolute shit show that is CDC's new guidance...
25/
Remarkable day for COVID #rapidtests
A Thread on @US_FDA NEW GUIDANCE!
FDA finally recognized Sensitivity of test *REGIMEN* is as/more important than single test
Sort of recognized virus load goes up & impacts Rapid Tests!
Sounds familiar! (ca 2020)
https://t.co/lIQB572pdQ
1/
Exciting news! Findings from a new study led by @UMassChan researchers are the basis for a safety communication issued by the @US_FDA today regarding serial use of at-home antigen tests for COVID-19.
Congrats to my friends, @NateHafer@herbert_carly and the team!
FDA's note comes after a new study (released last week as a preprint) finds increased sensitivity compared with PCR with serial testing.
- Symptomatic: 82% after 1 test, 93% after 2, 94% after 3
- Asymptomatic: 39% after 1 test, 62% after 2, 79% after 3
https://t.co/1L5IGVGQyS
Excited to share the launch of the Yale Science Fellows program!
This is a new program for recent PhD grads featuring:
- $90k stipend
- mentored research + research funding
- structured transition to an independent faculty position!
Apply here: https://t.co/mxi0bvNDgg
Today, the @US_FDA is advising people to perform repeat, or serial, testing following a negative result on any at-home COVID-19 antigen test, whether or not you have symptoms. Find out more: https://t.co/8Pl78sAw09
A new study by UMass Chan researchers and partners supported by the @NIH#RADx initiative finds when at-home #COVID19 tests are most effective at detecting infection. The findings have prompted @US_FDA recommendations: https://t.co/wRYctL12B3 @NateHafer@NIBIBgov@COVID19TestUs